Quick Answer
Anixa Biosciences Inc reported Net Income of -$10.93 million for fiscal year 2025.
Anixa Biosciences Inc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$10.93M | +13.0% |
| 2024 | -$12.55M | -28.0% |
| 2023 | -$9.81M | +27.8% |
| 2022 | -$13.60M | -4.9% |
| 2021 | -$12.95M | -29.3% |
| 2020 | -$10.02M | +14.0% |
| 2019 | -$11.65M | +16.8% |
| 2018 | -$14.00M | -179.4% |
| 2017 | -$5.01M | +0.1% |
| 2016 | -$5.02M | -263.8% |
| 2015 | -$1.38M | +85.6% |
| 2014 | -$9.61M | +4.7% |
| 2013 | -$10.08M | -137.0% |
| 2012 | -$4.25M | +42.4% |
| 2011 | -$7.38M | -42.6% |
| 2010 | -$5.18M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | -$2.56M | +19.4% | -13.6% |
| July 31, 2025 | -$2.26M | +31.1% | +19.1% |
| April 30, 2025 | -$2.79M | +11.1% | +12.4% |
| January 31, 2025 | -$3.18M | +2.2% | +2.8% |
| July 31, 2024 | -$3.28M | -30.5% | -4.4% |
| April 30, 2024 | -$3.14M | -37.2% | +3.6% |
| January 31, 2024 | -$3.25M | -40.2% | -29.6% |
| July 31, 2023 | -$2.51M | +8.6% | -9.7% |
- Anixa Biosciences Inc showed an increase of +13.0% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, Anixa Biosciences Inc’s net income has declined by 111.1% (from -$5.18 million to -$10.93 million).
- The most recent figure is from Anixa Biosciences Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: